Notably, 18F-PSMA-1007 PET/CT may detect metastatic disease in a significant number of patients with negative standard imaging for metastatic spread of PCa, changing the clinical management in about 20% of PCa patients at staging [24]. Here, FOLH1 is linked to metastatic neoplasm.